CBIO
Crescent Biopharma Inc
NASDAQ · Biotechnology
$9.51
+0.10 (+1.06%)
Open$9.52
Previous Close$9.41
Day High$9.79
Day Low$9.35
52W High$26.97
52W Low$14.78
Volume—
Avg Volume287.0K
Market Cap262.06M
P/E Ratio21.87
EPS$0.94
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+190.9% upside
Current
$9.51
$9.51
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 57.99M | 51.60M | 54.22M |
| Net Income | 180.8K | 210.8K | 183.8K |
| Profit Margin | 0.3% | 0.4% | 0.3% |
| EBITDA | 390.2K | 358.0K | 370.7K |
| Free Cash Flow | 84.1K | 101.4K | 117.1K |
| Rev Growth | +8.6% | +24.1% | +21.6% |
| Debt/Equity | 0.52 | 0.47 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |